B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Odanacatib

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Odanacatib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

boceprevir
6 shared targets
cyano
4 shared targets
balicatib
4 shared targets
telaprevir
5 shared targets
gallinamide
3 shared targets
k
3 shared targets
e
4 shared targets
pf
2 shared targets
echinatin
2 shared targets
calpeptin
2 shared targets
Loading evidence profile...

This evidence profile for Odanacatib is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.